RAS Quantification in Patients With Aliskiren or Candesartan (RASQAL)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified April 2013 by Medical University of Vienna.
Recruitment status was  Recruiting
Information provided by (Responsible Party):
Marcus Saemann, Medical University of Vienna
ClinicalTrials.gov Identifier:
First received: April 4, 2013
Last updated: April 8, 2013
Last verified: April 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: September 2013 (Final data collection date for primary outcome measure)